When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitementread on
In 2015, we pioneered a moneyball for biotech approach, pooling projects and promising early-stage research from academia together under onefinancial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries and empower people to solve problems. If youre someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, well ask why not? and help reengineer the future of biopharma.
Eidos Therapeutics, an affiliate within BridgeBio Pharma, is a commercial-stage biopharmaceutical company focused on Transthyretin Amyloid Cardiomyopathy (ATTR-CM).
The Associate Director, Biostatistics is responsible for statistical activities in support of Medical Affairs activities, including contributing to providing scientific and methodological expertise to support medical strategy, publications, and external engagements. This role will focus on the design, execution, interpretation, and communication of analyses that inform medical decision-making, health outcomes, and scientific exchange. A successful candidate will also interact with internal and external cross-functional study teams, supporting interactions with the medical community, and manage contract research organization (CRO) programmers and statisticians in preparing analysis files and performing statistical analyses.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Skill Development & Career Paths:
At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits.
#J-18808-Ljbffr